Curated News:

NEJM

Add to Favorites Subscribe Share
fbshare-NEJM

Showing results

110 of 360
Newswise: Secondary surgery does not improve overall survival for recurrent ovarian cancer patients
  • Embargo expired:
    13-Nov-2019 5:00 PM EST

Secondary surgery does not improve overall survival for recurrent ovarian cancer patients

University of Texas M. D. Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.

Channels: All Journal News, Cancer, Surgery, Women's Health, NEJM,

Released:
12-Nov-2019 10:00 AM EST

Three-drug combo improves lung function in most common genetic form of cystic fibrosis

UT Southwestern Medical Center

A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

Channels: All Journal News, Children's Health, Clinical Trials, Digestive Disorders, Genetics, Pharmaceuticals, Respiratory Diseases and Disorders, NEJM,

Released:
31-Oct-2019 4:55 PM EDT
Research Results
mmc-logo.gif

Mayo Clinic studies patient privacy in MRI research

Mayo Clinic

Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.

Channels: All Journal News, Patient Safety, Technology, National Institutes of Health (NIH), NEJM,

Released:
23-Oct-2019 5:00 PM EDT
Research Results
color-without-R-core-standard.png

Beta-blocker trial does not reduce risks for COPD patients

University of Alabama at Birmingham

Dransfield said their findings showed no evidence that beta-blockers were helpful in reducing the risk of exacerbations.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Respiratory Diseases and Disorders, NEJM,

Released:
21-Oct-2019 10:05 AM EDT
Research Results
baylorscottandwhite.jpg

New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn

Baylor Scott and White Health

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).

Channels: All Journal News, Clinical Trials, Digestive Disorders, Surgery, NEJM,

Released:
17-Oct-2019 7:00 AM EDT
Research Results
JOS-logo.gif

Artificial pancreas system better controls blood glucose levels than current technology

Joslin Diabetes Center

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.The study showed that the system improved participants’ blood glucose control throughout the day and overnight.

Channels: All Journal News, Clinical Trials, Diabetes, Digestive Disorders, Kidney Disease, NEJM,

Released:
16-Oct-2019 8:05 PM EDT
Research Results
mmc-logo.gif

Según estudios, la lesión pulmonar asociada al uso del cigarrillo electrónico podría ser producto de los vapores tóxicos

Mayo Clinic

La investigación sobre la anatomía patológica de la lesión pulmonar asociada al uso del cigarrillo electrónico está en etapas iniciales, pero, de acuerdo con un estudio llevado adelante por Mayo Clinic que se publicó en el The New England Journal of Medicine, las lesiones pulmonares por uso del cigarrillo electrónico posiblemente son producto de la intoxicación directa o del daño en los tejidos provocado por los vapores químicos nocivos.

Channels: All Journal News, Respiratory Diseases and Disorders, Smoking, NEJM,

Released:
3-Oct-2019 5:05 PM EDT
Research Results
mmc-logo.gif

Lesão pulmonar associada ao uso de cigarros eletrônicos pode ser causada por vapores químicos tóxicos, segundo estudo

Mayo Clinic

Um estudo liderado pela Mayo Clinic publicado no The New England Journal of Medicine descobriu que as lesões pulmonares causadas pelo uso de cigarros eletrônicos provavelmente são causadas por toxicidade direta ou dano tecidual causado por vapores químicos nocivos.

Channels: All Journal News, Respiratory Diseases and Disorders, NEJM,

Released:
2-Oct-2019 5:05 PM EDT
Research Results
mmc-logo.gif

Mit dem Vaping verbundene Lungenverletzungen können von giftigen chemischen Dämpfen verursacht werden, findet Studie heraus

Mayo Clinic

Eine von der Mayo Clinic geleitete Studie, die in The New England Journal of Medicine veröffentlicht wurde, hat ergeben, dass Lungenverletzungen durch Vaping höchstwahrscheinlich von der direkten Toxizität oder Gewebeverletzungen durch giftige chemische Dämpfe verursacht.

Channels: All Journal News, Respiratory Diseases and Disorders, Smoking, NEJM,

Released:
2-Oct-2019 5:05 PM EDT
Research Results

Showing results

110 of 360

Chat now!
1.05062